Malte Lenders (M Lenders)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Topics

Left Ventricular

Replacement Therapy

Hypertrophic Cardiomyopathy

Top Venues

Journal of medical genetics

Journal of the American Society of Nephrology : JASN

Journal of inherited metabolic disease

This page only lists publications with an associated author ORCID identifier.

Publications

Malte Lenders, Eva Brand
Comment to: Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study-determination of immunogenicity. Journal of medical genetics 61 (6) (2024)
Malte Lenders, Eva Brand
Comment to: Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study-determination of immunogenicity. Journal of medical genetics 61 (6) (2024)
Malte Lenders, Eva Brand
Comment to: Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study-determination of immunogenicity. Journal of medical genetics (2024)
Malte Lenders, Eva Brand
Fabry disease - a multisystemic disease with gastrointestinal manifestations. Gut microbes 14 (1) (2022)
Malte Lenders, Peter Nordbeck, Christine Kurschat, Maria Eveslage, Nesrin Karabul, Jessica Kaufeld, Julia B Hennermann, Monica Patten, Markus Cybulla, Jonas Müntze, Nurcan Üçeyler, Dan Liu, Anibh M Das, Claudia Sommer, Christian Pogoda, Stefanie Reiermann, Thomas Duning, Jens Gaedeke, Katharina von Cossel, Daniela Blaschke, Stefan-Martin Brand, W Alexander Mann, Christoph Kampmann, Nicole Muschol, Sima Canaan-Kühl, Eva Brand
Treatment of Fabry Disease management with migalastat-outcome from a prospective 24 months observational multicenter study (FAMOUS). European heart journal. Cardiovascular pharmacotherapy 8 (3) (2022)
Malte Lenders, Eva Brand
Mechanisms of Neutralizing Anti-drug Antibody Formation and Clinical Relevance on Therapeutic Efficacy of Enzyme Replacement Therapies in Fabry Disease. Drugs 81 (17) (2021)
Malte Lenders, Peter Nordbeck, Sima Canaan-Kühl, Lukas Kreul, Thomas Duning, Lora Lorenz, Christian Pogoda, Stefan-Martin Brand, Christoph Wanner, Eva Brand
Treatment switch in Fabry disease- a matter of dose? Journal of medical genetics 58 (5) (2020)
Malte Lenders, Peter Nordbeck, Christine Kurschat, Nesrin Karabul, Jessica Kaufeld, Julia B Hennermann, Monica Patten, Markus Cybulla, Jonas Müntze, Nurcan Üçeyler, Dan Liu, Anibh M Das, Claudia Sommer, Christian Pogoda, Stefanie Reiermann, Thomas Duning, Jens Gaedeke, Katharina Stumpfe, Daniela Blaschke, Stefan-Martin Brand, W Alexander Mann, Christoph Kampmann, Nicole Muschol, Sima Canaan-Kühl, Eva Brand
Treatment of Fabry's Disease With Migalastat: Outcome From a Prospective Observational Multicenter Study (FAMOUS). Clinical pharmacology and therapeutics 108 (2) (2020)
Malte Lenders, Franciska Stappers, Christoph Niemietz, Boris Schmitz, Michel Boutin, Paula Johanna Ballmaier, Andree Zibert, Hartmut Schmidt, Stefan-Martin Brand, Christiane Auray-Blais, Eva Brand
Mutation-specific Fabry disease patient-derived cell model to evaluate the amenability to chaperone therapy. Journal of medical genetics 56 (8) (2019)
Franciska Stappers, David Scharnetzki, Boris Schmitz, Dominique Manikowski, Stefan-Martin Brand, Kay Grobe, Malte Lenders, Eva Brand
Neutralising anti-drug antibodies in Fabry disease can inhibit endothelial enzyme uptake and activity. Journal of inherited metabolic disease 43 (2) (2019)
Malte Lenders, Eva Brand
Effects of Enzyme Replacement Therapy and Antidrug Antibodies in Patients with Fabry Disease. Journal of the American Society of Nephrology : JASN 29 (9) (2018)
Malte Lenders, Boris Schmitz, Stefan-Martin Brand, Eva Brand
Neutralizing anti-drug antibodies in Fabry disease have no obvious clinical impact? Orphanet journal of rare diseases 13 (1) (2018)
Malte Lenders, D Oder, A Nowak, S Canaan-Kühl, L Arash-Kaps, C Drechsler, B Schmitz, P Nordbeck, J B Hennermann, C Kampmann, S Reuter, S-M Brand, C Wanner, E Brand
Impact of immunosuppressive therapy on therapy-neutralizing antibodies in transplanted patients with Fabry disease. Journal of internal medicine 282 (3) (2017)